DEA Proposes New Import, Export Restrictions for para-Methoxymethamphetamine
The Drug Enforcement Administration is proposing to list para-methoxymethamphetamine (PMMA), a drug similar to methylenedioxymethamphetamine (MDMA) that is also sold as “ecstasy,” as a schedule I substance under the Controlled Substances Act. “If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle PMMA,” DEA said. Comments are due June 15.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
(Federal Register 05/15/20)